← Back to headlines
Tempus Receives FDA Clearance for Pulmonary Hypertension AI
Tempus has obtained FDA clearance for its artificial intelligence product designed for pulmonary hypertension.
24 Aug, 13:06 — 24 Aug, 13:06
Sources
Showing 1 of 1 sources
